Sapina, A. I., Varlamova, Y. Y., Papyrina, M. G., Bezymyannyy, A. S., Kordzaya, E. L., & Vasilyeva, E. Y. (2025). Evaluation of lipoprotein(a) — a novel cardiovascular risk factor in patients with atherosclerotic cardiovascular diseases receiving PCSK9-targeted therapy in Russian real-world practice. «FIRMA «SILICEA» LLC.
Παραπομπή σε μορφή Chicago (17η εκδ.)Sapina, A. I., Yu. Yu Varlamova, M. G. Papyrina, A. S. Bezymyannyy, E. L. Kordzaya, και E. Yu Vasilyeva. Evaluation of Lipoprotein(a) — a Novel Cardiovascular Risk Factor in Patients with Atherosclerotic Cardiovascular Diseases Receiving PCSK9-targeted Therapy in Russian Real-world Practice. «FIRMA «SILICEA» LLC, 2025.
Παραπομπή σε μορφή MLA (9th εκδ.)Sapina, A. I., et al. Evaluation of Lipoprotein(a) — a Novel Cardiovascular Risk Factor in Patients with Atherosclerotic Cardiovascular Diseases Receiving PCSK9-targeted Therapy in Russian Real-world Practice. «FIRMA «SILICEA» LLC, 2025.